(19)
(11) EP 4 142 731 A1

(12)

(43) Date of publication:
08.03.2023 Bulletin 2023/10

(21) Application number: 21743056.0

(22) Date of filing: 28.04.2021
(51) International Patent Classification (IPC): 
A61K 31/505(2006.01)
A61P 11/00(2006.01)
 A61P 31/14(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/505; A61P 11/00; A61P 31/14
(86) International application number:
PCT/EP2021/061034
(87) International publication number:
WO 2021/219671 (04.11.2021 Gazette 2021/44)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 28.04.2020 US 202063016611 P
06.05.2020 EP 20173352
11.06.2020 EP 20179550

(71) Applicant: Noorik Biopharmaceuticals AG
4052 Basel (CH)

(72) Inventor:
  • NAVARRO, Iker
    4125 Riehen (CH)

(74) Representative: ABG Intellectual Property Law, S.L. 
Avenida de Burgos, 16D Edificio Euromor
28036 Madrid
28036 Madrid (ES)

   


(54) TREATMENT OF PULMONARY COMPLICATIONS OF CORONAVIRUS INFECTIONS